Open and distance university of Mexico

Subject: CLINICAL NUTRITION I

U2. Nutrition in metabolic diseases
with disorders of lipids, proteins and thyroid glands
Evidence of learning. NCL1 U1 Evidence of Learning

Online teacher: Marisol Orihuela Torres

Group: NA-NNCL1-2202-B2-002

Bachelor: Applied Nutrition

Alejandra Guadalupe Quiroga Sánchez
ES202100469

Delivery date: October 27, 2022

 INTRODUCTION

Metabolic diseases are characterized by having some disorder of the lipids, proteins and thyroid
glands. Analyzing the diseases are part of a sequence of pathologies that have transformed the
epidemiological panorama present in the country, since they are the main prevalence of mortality in
the Adults.

The study is the knowledge in the procedure of these pathologies, the first thing that must be done is
the establishment of a comprehensive nutritional diagnosis to implement clinical judgments through
semiology and to be able to conceptualize the most appropriate nutritional therapy with the necessary
information for the formulation of different diagnostic and therapeutic hypotheses, in the management
and solution of clinical cases.

DEVELOPMENT

Make a diagram or mental map where you mention lipid disorder diseases including diagnosis
(tests), signs, etiology and nutritional treatment
Prepare a synoptic table where you mention diseases due to protein disorders, their
symptoms, diagnosis, etiology and nutritional treatment.
Design a flow chart where you explain thyroid gland disorders, as well as symptoms,
diagnosis, causes and nutritional treatment.
 CONCLUSION

In conclusion; seeing previously the carbohydrate diseases. Knowing during the study of these
diseases are the group in metabolic syndrome, if any of them exists therefore it would be considered
that way. Now, to determine a diagnosis, the use of signs, symptoms, etiology and laboratory tests is
needed to follow up, in this way providing accurate treatment; In which you can maintain your state of
health or in other cases, prevent the disease. Like, in each disease the possible causes appear,
especially in dyslipidemia, the consumption of foods rich in fat, in your lifestyle or other conditions that
further complicate the appearance of these. Which, an effective treatment will be based on its causes
and the foods that work well for a patient. On the other hand, in proteins it is very different, these occur
due to hereditary metabolism, or innate errors in the metabolism of amino acids, the initial defect is
due to an alteration of the DNA which can affect the excretion of an enzyme such as producing from
more to less and others affecting transport, in its causes, provides the substrate that acts.

Unadm (Sf) mentions… The treatment is carried out by restricting the amount of accumulated
substrate. Supplementation of adequate amounts of protein and amino acids ensure acceptable
growth and development.

Finally, in the thyroid disorder, from my perspective, I understand these two diseases as
hyperthyroidism that appears due to a tumor or infection. On the contrary, in hypothyroidism it appears
due to radiation of the thyroid tumor. In the aspect of hyperthyroidism treatment, it is carried out by
increasing the activity of anabolic and catabolic reactions. As a result, it has a catabolism that
compromises all its nutrients, therefore it will be offered a diet with high energy, nutrient-rich foods.
Likewise, the opposite happens with hypothyroidism, which in its final state will have many nutrients in
its body and a better solution will be to subtract a little of them.
References

Candil S. (2018) Manual of THYROID PATHOLOGY. Seen. EDITORIAL APPROACH.

https://www.fundacionmercksalud.com/wp-content/uploads/2018/05/Manual-de-patologia-
tiroidea_VERSION-ONLINE.pdf
Rodríguez A. (Sf) Hypothyroidism nutritional recommendations. National Polytechnic Institute.
Consulted on October 27, 2022 from
https://www.ipn.mx/assets/files/daes/docs/Atencionalasalud/InfoInteres/Hipotiroidismo.pdf

Fernandez M. (200) nutrition topics. Diet therapy. Havana: Medical Sciences Editorial. 229 p. Retaken
from: dietoterapia.pdf
Bravo P. (2015) What should the pediatrician know about hyperphenylalaninemia? Chilean Pediatrics. Elsevier.
Vol. 86. No. 3. pages 214-218. Taken from:
https://www.elsevier.es/es-revista-revista-chilena-pediatria-219-pdf- S0370410615000674
Colomer M. (October, 2004) Urea cycle disorders. Offarm. Elsevier . Vol. 23. No. 9. pages 136-138.
Retaken from: https://www.elsevier.es/es-revista-offarm-4-articulo-trastornos-del-ciclo-urea-13067358
Roussaud F. (February 7, 2020) Cystinuria. CYBERER. Retrieved on October 27, 2022 from,
file:///C:/Users/Manrique/Downloads/nefrologia-dia-272%20(1).pdf
Flores M. (July 2014) From the disruption in tryptophan metabolism to clinical complexity
of Hartnup disease. Medical journal and research. Vol. 2. No. 2. pages 170-173.
Taken from:
https://www.elsevier.es/es-revista-revista-medicina-e-investigacion-353-articulo-de-disrupcion-el-metabolismo-
del-X2214310614603849
UnADM (Sf) U2. Nutrition in metabolic diseases with disorders of lipids, proteins
and thyroid glands. Open and distance university of Mexico. Recovered on October 27
2022, NNCL1_U2_Contenido.pdf